Biocompatible and label-free separation of cancer cells from cell culture lines from white blood cells in ferrofluids

Wujun Zhao, Rui Cheng, So Hyun Lim, Joshua R. Miller, Weizhong Zhang, Wei Tang, Jin Xie, Leidong Mao

Lab on a Chip · 2017 · 70 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

. The separation efficiencies were 80 ± 3%, 81 ± 5%, 82 ± 5%, 82 ± 4%, and 86 ± 6% for A549 lung cancer, H1299 lung cancer, MCF-7 breast cancer, MDA-MB-231 breast cancer, and PC-3 prostate cancer cell lines, respectively. The separated cancer cells' purity was between 25.3% and 28.8%. In addition, the separated cancer cells from this strategy showed an average short-term viability of 94.4 ± 1.3%, and these separated cells were cultured and demonstrated normal proliferation to confluence even after the separation process. Owing to its excellent biocompatibility and label-free operation and its ability to recover low concentrations of cancer cells from white blood cells, this method could lead to a promising tool for rare cell separation.

References

36